Evidence map›Paper›PMID 42286391›Full record

ArticleEJNMMI research2026

Early timepoint

Stephan Settelmeier, Lukas Kessler, Noah Hammersen, Maria Papathanasiou, Christoph Rischpler, Alexander Carpinteiro, Sara Oubari, Lars Michel, Julia Vogel, Tim Wollenweber and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Stephan SettelmeierDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Lukas KesslerWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Noah HammersenDepartment of Nuclear Medicine, University Hospital Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Maria PapathanasiouDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Christoph RischplerDepartment of Nuclear Medicine, University Hospital Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Alexander CarpinteiroWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Sara OubariWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Lars MichelDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Julia VogelDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Tim WollenweberDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Jing NingDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Marcus HackerDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Clemens P SpielvogelDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Zohreh VarastehWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Wolfgang P FendlerWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Francesco BarbatoWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Pedro Fragoso CostaWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Stephan LeyserDepartment of Nuclear Medicine, University Hospital Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Tienush RassafDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Ken HerrmannWest German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Tugce Telli *West German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
David Kersting *West German Amyloidosis Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany. david.kersting@uni-due.de.ORCID http://orcid.org/0000-0002-8451-1830

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac transthyretin amyloidosis (ATTR-CM) is a progressive myocardial disease ultimately leading to heart failure. Standard diagnostic workup includes

results50 patients undergoing

conclusionsEarly

Indexed as

ATTRCardiac amyloidosisDPD-SPECTNuclear cardiologyPerugini score

Identifiers

PMID42286391
PMCPMC13263361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.